keyword
https://read.qxmd.com/read/38621701/blood-cell-count-ratios-at-baseline-are-associated-with-initial-clinical-response-to-clozapine-in-treatment-resistant-clozapine-na%C3%A3-ve-schizophrenia-spectrum-disorder
#1
JOURNAL ARTICLE
Vicent Llorca-Bofí, Miquel Bioque, Santiago Madero, Andrea Mallorquí, Cristina Oliveira, Marina Garriga, Eduard Parellada, Clemente García-Rizo
BACKGROUND: Clozapine is the recommended treatment for managing treatment-resistant schizophrenia (TRS), and immunological mechanisms may be involved in its unique antipsychotic efficacy. This study investigated whether baseline immune abnormalities measured with blood cell count ratios can predict the clinical response after initiating treatment with clozapine in patients with clozapine naïve TRS. METHODS: A longitudinal design was developed, involving 32 patients diagnosed with treatment-resistant, clozapine-naïve schizophrenia-spectrum disorder...
April 15, 2024: Pharmacopsychiatry
https://read.qxmd.com/read/38268596/exploring-the-risk-of-infection-events-in-patients-with-asthma-receiving-anti-il-5-monoclonal-antibodies-a-rapid-systematic-review-and-a-meta-analysis
#2
REVIEW
Riccardo Giossi, Arianna Pani, Jan Schroeder, Francesco Scaglione
INTRODUCTION: Benralizumab, mepolizumab, and reslizumab are novel monoclonal antibodies approved for asthma, targeting eosinophilic inflammation. Benralizumab is directed against IL-5 receptor (IL-5R), while mepolizumab and reslizumab are directed against IL-5. The three drugs cause a reduction in eosinophils, but benralizumab also causes a cytotoxic effect on eosinophils and basophils. Recently, it has been reported that suboptimal responders to benralizumab presented exacerbations associated with concomitant infections and sputum neutrophilia and the incidence of infections was greater in patients receiving benralizumab compared to mepolizumab and reslizumab...
January 15, 2024: Heliyon
https://read.qxmd.com/read/38113870/atopy-and-response-to-omalizumab-treatment-in-chronic-spontaneous-urticaria
#3
Célia Costa, Leonor Esteves Caldeira, Marisa Paulino, Diana F Santos, Susana L Silva
INTRODUCTION: The possible influence of sensitization to aeroallergens on omalizumab response in chronic spontaneous urticaria (CSU) has been insufficiently investigated. This study's aim was to investigate atopy's influence on omalizumab response in CSU patients. METHOD: Retrospective study of CSU patients followed at a Portuguese Urticaria Center of Reference and Excellence (UCARE), treated with omalizumab for at least 6 months, between 2015 and 2022. At T0, all patients underwent quantification of specific immunoglobulin E (IgE) for total extract of most prevalent aeroallergens (ImmunoCAP Thermo Fisher Scientific®) and were divided in 2 groups, according to their response to omalizumab during the first 16 weeks of treatment: responders (R) (UAS7 <7) versus partial (PR) (UAS7 = 7-15) and nonresponders (UAS7 >15)...
December 19, 2023: International Archives of Allergy and Immunology
https://read.qxmd.com/read/37719698/exploring-novel-genetic-and-hematological-predictors-of-response-to-neoadjuvant-chemoradiotherapy-in-locally-advanced-rectal-cancer
#4
JOURNAL ARTICLE
Mladen Marinkovic, Suzana Stojanovic-Rundic, Aleksandra Stanojevic, Marija Ostojic, Dusica Gavrilovic, Radmila Jankovic, Natasa Maksimovic, Rafael Stroggilos, Jerome Zoidakis, Sergi Castellví-Bel, Remond J A Fijneman, Milena Cavic
Introduction: The standard treatment for locally advanced rectal cancer (LARC) is neoadjuvant chemoradiotherapy (nCRT). To select patients who would benefit the most from nCRT, there is a need for predictive biomarkers. The aim of this study was to evaluate the role of clinical, pathological, radiological, inflammation-related genetic, and hematological parameters in the prediction of post-nCRT response. Materials and methods: In silico analysis of published transcriptomics datasets was conducted to identify candidate genes, whose expression will be measured using quantitative Real Time PCR (qRT-PCR) in pretreatment formaline-fixed paraffin-embedded (FFPE) samples...
2023: Frontiers in Genetics
https://read.qxmd.com/read/37557083/anti-tpo-igg-total-ige-ratio-biomarker-for-omalizumab-response-prediction-in-chronic-spontaneous-urticaria
#5
JOURNAL ARTICLE
Rita Brás, Leonor Esteves Caldeira, Ana Bernardino, Célia Costa
BACKGROUND: According to recently published data, low total IgE, elevated IgG-anti-TPO, and a high IgG-anti-TPO/total IgE ratio are good biomarkers for subtype IIb autoimmune chronic spontaneous urticaria (CSU), which is frequently refractory to antihistamines and omalizumab. OBJECTIVES: The aim of the study was to evaluate IgG-anti-TPO/total IgE ratio's utility in omalizumab response prediction. METHODS: Retrospective study of CSU patients treated with omalizumab at a UCARE between January 2009 and February 2022...
2023: International Archives of Allergy and Immunology
https://read.qxmd.com/read/37494666/a-plasma-mir-193b-365-signature-combined-with-age-and-glycemic-status-predicts-response-to-lactococcus-lactis-based-antigen-specific-immunotherapy-in-new-onset-type-1-diabetes
#6
JOURNAL ARTICLE
Gabriele Sassi, Giada Licata, Giuliana Ventriglia, Amber Wouters, Pierre Lemaitre, Ruth Seurinck, Alessia Mori, Giuseppina Emanuela Grieco, Samal Bissenova, Darcy Ellis, Silvia Caluwaerts, Pieter Rottiers, Niels Vandamme, Chantal Mathieu, Francesco Dotta, Conny Gysemans, Guido Sebastiani
Immunomodulation combined with antigen therapy holds great promise to arrest autoimmune type 1 diabetes, but clinical translation is hampered by a lack of prognostic biomarkers. Lowdose anti-CD3 plus Lactococcus lactis (L. lactis) bacteria secreting proinsulin and IL-10 reversed new-onset disease in non-obese diabetic (NOD) mice, yet some mice were resistant to the therapy. Using microRNA (miRNA) profiling, six miRNAs (i.e., miR-34a-5p, miR-125a- 3p, miR-193b-3p, miR-328, miR-365-3p, and miR-671-3p) were identified as differentially expressed in plasma of responder versus non-responder mice before study entry...
July 26, 2023: Diabetes
https://read.qxmd.com/read/37202383/single-cell-transcriptomics-clarifies-the-basophil-differentiation-trajectory-and-identifies-pre-basophils-upstream-of-mature-basophils
#7
JOURNAL ARTICLE
Kensuke Miyake, Junya Ito, Jun Nakabayashi, Shigeyuki Shichino, Kenji Ishiwata, Hajime Karasuyama
Basophils are the rarest granulocytes and are recognized as critical cells for type 2 immune responses. However, their differentiation pathway remains to be fully elucidated. Here, we assess the ontogenetic trajectory of basophils by single-cell RNA sequence analysis. Combined with flow cytometric and functional analyses, we identify c-Kit- CLEC12Ahi pre-basophils located downstream of pre-basophil and mast cell progenitors (pre-BMPs) and upstream of CLEC12Alo mature basophils. The transcriptomic analysis predicts that the pre-basophil population includes previously-defined basophil progenitor (BaP)-like cells in terms of gene expression profile...
May 18, 2023: Nature Communications
https://read.qxmd.com/read/37148201/role-of-clinical-biomarkers-in-predicting-the-effectiveness-of-omalizumab
#8
JOURNAL ARTICLE
Qing Zhang, Chunxiao Li, Jingxuan Wan, Mengyuan Zhang, Ying Nong, Jiangtao Lin
OBJECTIVE: To explore whether baseline clinical biomarkers and characteristics can be used to predict the responsiveness of omalizumab. METHODS: We retrospectively analyzed a cohort of patients with severe asthma who received omalizumab treatment and collected their baseline data and relevant laboratory examination results along with case records of omalizumab treatment responsiveness after 16 weeks. We compared the differences in variables between the group of patients that responded to omalizumab therapy and the non-responder group, and then performed univariate and multivariate logistic regression...
2023: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/36973953/remibrutinib-inhibits-hives-effector-cells-stimulated-by-serum-from-chronic-urticaria-patients-independently-of-fc%C3%AE%C2%B5r1-expression-level-and-omalizumab-clinical-response
#9
JOURNAL ARTICLE
Ramón Gimeno, Clara Ribas-Llauradó, David Pesque, Evelyn Andrades, Bruno Cenni, Barbara Ambros, Ramon Pujol, Ana M Giménez-Arnau
BACKGROUND: Despite advances in the treatment of chronic urticaria, in a significant percentage of the patients symptoms are not fully controlled with conventional approaches. New strategies under development include blocking intracellular mediators of mast cell and basophil activation. OBJECTIVE: We aim to investigate the effects of the Bruton's tyrosine kinase (BTK) inhibitor remibrutinib on human blood basophils and CD34+ -derived mast cells activation induced by serum obtained from chronic urticaria patients...
March 2023: Clinical and Translational Allergy
https://read.qxmd.com/read/36836557/deciphering-differential-behavior-of-immune-responses-as-the-foundation-for-precision-dosing-in-allergen-immunotherapy
#10
REVIEW
Antoine Magnan, Jean-François Nicolas, Davide Caimmi, Marc Vocanson, Thierry Haddad, Luc Colas, Silvia Scurati, Laurent Mascarell, Mohamed H Shamji
Like in many fields of medicine, the concept of precision dosing has re-emerged in routine practice in allergology. Only one retrospective study on French physicians' practice has addressed this topic so far and generated preliminary data supporting dose adaptation, mainly based on experience, patient profile understanding and response to treatment. Both intrinsic and extrinsic factors shape the individual immune system response to allergen immunotherapy (AIT). Herein, we focus on key immune cells (i.e., dendritic cells, innate lymphoid cells, B and T cells, basophils and mast cells) involved in allergic disease and its resolution to further understand the effect of AIT on the phenotype, frequency or polarization of these cells...
February 13, 2023: Journal of Personalized Medicine
https://read.qxmd.com/read/36766659/the-role-of-nasal-cytology-and-serum-atopic-biomarkers-in-paediatric-rhinitis
#11
JOURNAL ARTICLE
Giulia Dodi, Paola Di Filippo, Francesca Ciarelli, Annamaria Porreca, Fiorella Cazzato, Lorena Matonti, Sabrina Di Pillo, Giampiero Neri, Francesco Chiarelli, Marina Attanasi
A Nasal Provocation Test allows the differentiation of allergic and non-allergic rhinitis, but it is difficult and expensive. Therefore, nasal cytology is taking hold as an alternative. We carried out a cross-sectional study, including 29 patients with persistent rhinitis according to ARIA definition and negative skin prick tests. Nasal symptoms were scored from 0 to 5 using a visual analogue scale, and patients underwent blood tests to investigate blood cell count (particularly eosinophilia and basophilia), to analyze serum total and specific IgE and eosinophil cationic protein (ECP), and to perform nasal cytology...
February 2, 2023: Diagnostics
https://read.qxmd.com/read/36720390/omalizumab-in-chronic-spontaneous-urticaria-csu-real-life-experience-in-dose-interval-adjustments-and-treatment-discontinuation
#12
JOURNAL ARTICLE
Rita Brás, Célia Costa, Rita Limão, Leonor Esteves Caldeira, Marisa Paulino, Elisa Pedro
BACKGROUND: Data on real-life experience with omalizumab dose/interval adjustments are still limited, as well as on omalizumab discontinuation. OBJECTIVE: To evaluate efficacy and safety of omalizumab dose/interval adjustment in a Portuguese cohort of patients with chronic spontaneous urticaria (CSU) and to characterize those who discontinued omalizumab. METHODS: A retrospective study of patients who started omalizumab for CSU at a Portuguese Urticaria Center of Reference and Excellence (UCARE) was conducted between 2009 and 2021...
August 2023: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/36615181/igg-and-ige-autoantibodies-to-ige-receptors-in-chronic-spontaneous-urticaria-and-their-role-in-the-response-to-omalizumab
#13
JOURNAL ARTICLE
Carlo Alberto Maronese, Silvia Mariel Ferrucci, Chiara Moltrasio, Maurizio Lorini, Vincenzo Carbonelli, Riccardo Asero, Angelo Valerio Marzano, Massimo Cugno
Background: Chronic spontaneous urticaria (CSU) is defined as the recurrence of unprovoked transient wheals and itch for more than 6 weeks. Currently, there is an unmet need concerning response prediction in CSU. The present study investigated biomarkers of type I and type IIb autoimmunity as potential predictors of response to omalizumab in CSU. Materials and methods: Differences in levels of IgG and IgE autoantibodies targeting the high- and low-affinity IgE receptors (FcεRI and FcεRII, respectively), as well as spontaneous and specifically triggered leukotriene C (LTC)4 release by basophils from the investigated subjects, were evaluated in 18 consecutive, prospectively enrolled CSU patients and 18 age- and sex-matched, healthy non-atopic controls...
January 3, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/36436425/impact-of-antidepressant-treatment-on-complete-blood-count-parameters-and-inflammatory-ratios-in-adolescents-with-major-depressive-disorder
#14
JOURNAL ARTICLE
Pavarud Puangsri, Vinn Jinanarong, Putrada Ninla-Aesong
Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) are novel biomarkers of systemic inflammation in depression. This study aims to examines the impact of selective serotonin reuptake inhibitor (SSRI) treatment on complete blood count (CBC) parameters and inflammatory ratios in major depressive disorder (MDD). CBC parameters and inflammatory ratios were examined in a total of 45 drug-naive adolescents with MDD and were compared before and after SSRI treatment for 12 weeks and between responders and nonresponders...
November 17, 2022: Journal of Psychiatric Research
https://read.qxmd.com/read/36432660/exposure-of-the-basophilic-cell-line-ku812-to-liposomes-reveals-activation-profiles-associated-with-potential-anaphylactic-responses-linked-to-physico-chemical-characteristics
#15
JOURNAL ARTICLE
Alexander J Plant-Hately, Burcu Eryilmaz, Christopher A W David, Danielle E Brain, Bethany J Heaton, Yvonne Perrie, Neill J Liptrott
Lipidic nanoparticles (LNP), particularly liposomes, have been proven to be a successful and versatile platform for intracellular drug delivery for decades. Whilst primarily developed for small molecule delivery, liposomes have recently undergone a renaissance due to their success in vaccination strategies, delivering nucleic acids, in the COVID-19 pandemic. As such, liposomes are increasingly being investigated for the delivery of nucleic acids, beyond mRNA, as non-viral gene delivery vectors. Although not generally considered toxic, liposomes are increasingly shown to not be immunologically inert, which may have advantages in vaccine applications but may limit their use in other conditions where immunological responses may lead to adverse events, particularly those associated with complement activation...
November 15, 2022: Pharmaceutics
https://read.qxmd.com/read/36248902/basophils-activation-of-patients-with-chronic-spontaneous-urticaria-in-response-to-c5a-despite-failure-to-respond-to-ige-mediated-stimuli
#16
JOURNAL ARTICLE
Daiki Matsubara, Yuhki Yanase, Kaori Ishii, Shunsuke Takahagi, Akio Tanaka, Koichiro Ozawa, Michihiro Hide
Urticaria is characterized by the occurrence of wheals and flares in response to vasoactive mediators, such as histamine. Various studies have suggested the involvement of basophils in the pathogenesis of chronic spontaneous urticaria (CSU). However, histamine release from peripheral basophils in response to stimuli acting on the high affinity IgE receptor (FcϵRI) is impaired in many patients with CSU (non/low responders). We previously demonstrated that tissue factor (TF)s expressed on vascular endothelial cells in response to a combination of various stimuli, such as that of histamine and lipopolysaccharide (LPS), activates the extrinsic coagulation pathway and produces anaphylatoxin, complement 5a (C5a), which then activates basophils and mast cells via the C5a receptor (C5aR)...
2022: Frontiers in Immunology
https://read.qxmd.com/read/36058929/association-of-peripheral-basophils-with-tumor-m2-macrophage-infiltration-and-outcomes-of-the-anti-pd-1-inhibitor-plus-chemotherapy-combination-in-advanced-gastric-cancer
#17
JOURNAL ARTICLE
Chaorui Wu, Yaopeng Qiu, Renyi Zhang, Xiaoqing Li, Huayuan Liang, Minghao Wang, Fengping Li, Mansheng Zhu, Gengtai Ye, Hao Liu, Guoxin Li, Liying Zhao
BACKGROUND: Although the anti-programmed death-1 (PD-1) inhibitor plus chemotherapy combination has been approved as the standard first-line treatment for advanced gastric cancer, a proportion of patients do not significantly benefit from this therapy. Who would respond poorly to this treatment and the underlying mechanisms of treatment failure are far from clear. METHODS: We retrospectively analyzed the associations between the peripheral basophils at baseline and clinical outcomes in 63 advanced gastric cancer patients treated with anti-PD-1 plus chemotherapy and 54 patients treated with chemotherapy alone...
September 4, 2022: Journal of Translational Medicine
https://read.qxmd.com/read/35853771/omalizumab-versus-cyclosporin-a-for-the-treatment-of-chronic-spontaneous-urticaria-can-we-define-better-responding-endotypes
#18
JOURNAL ARTICLE
Emek Kocatürk, Emel Bülbül Başkan, Özlem Su Küçük, Mustafa Özdemir, Sinem Örnek, Pelin Kuteyla Can, Eda Haşal, Burhan Engin, Nilgün Atakan, Erkan Alpsoy
BACKGROUND: Chronic Spontaneous Urticaria (CSU) is characterized by recurrent wheals and/or angioedema for longer than 6-weeks. Guidelines recommend Omalizumab (Oma) as first-line and Cyclosporine-A (Cs-A) as second-line treatment in antihistamine resistant CSU. This step-wise algorithm might be time-consuming and costly. OBJECTIVE: To determine indicators of response to Oma or Cs-A in CSU patients. METHODS: We retrospectively analyzed data from seven centers in Turkey; the inclusion criteria for patients were to receive both Oma and Cs-A treatment (not concurrently) at some point in time during their follow-up...
July 16, 2022: Anais Brasileiros de Dermatologia
https://read.qxmd.com/read/35626115/single-cell-analyses-of-a-novel-mouse-urothelial-carcinoma-model-reveal-a-role-of-tumor-associated-macrophages-in-response-to-anti-pd-1-therapy
#19
JOURNAL ARTICLE
Dongbo Xu, Li Wang, Kyle Wieczorek, Yali Zhang, Zinian Wang, Jianmin Wang, Bo Xu, Prashant K Singh, Yanqing Wang, Xiaojing Zhang, Yue Wu, Gary J Smith, Kristopher Attwood, Yuesheng Zhang, David W Goodrich, Qiang Li
Approximately 80% of patients with advanced bladder cancer do not respond to immune checkpoint inhibitor (ICI) immunotherapy. Therefore, there is an urgent unmet need to develop clinically relevant preclinical models so that factors governing immunotherapy responses can be studied in immunocompetent mice. We developed a line of mouse triple knockout (TKO: Trp53 , Pten , Rb1 ) urothelial carcinoma organoids transplanted into immunocompetent mice. These bladder tumors recapitulate the molecular phenotypes and heterogeneous immunotherapy responses observed in human bladder cancers...
May 19, 2022: Cancers
https://read.qxmd.com/read/35625773/hypersensitivity-reactions-to-iodinated-contrast-media
#20
REVIEW
Tsu-Man Chiu, Sung-Yu Chu
At present, iodinated contrast media (ICM) are mostly non-ionic, have low osmolality, and are safe. Even if adverse drug reactions (ADRs) occur, most are chemo-toxic symptoms and require only observation or H1 antihistamines. However, rare, unpredictable, and even life-threatening hypersensitivity can still occur. The aim of this review is to summarize the issues that all relevant staff need to know about and be able to respond to. The most significant risk factor for ICM hypersensitivity is a history of ICM hypersensitivity...
April 30, 2022: Biomedicines
keyword
keyword
51165
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.